Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1985 Apr;19(4):459–470. doi: 10.1111/j.1365-2125.1985.tb02671.x

Lung function and plasma levels of thromboxane B2, 6-ketoprostaglandin F1 alpha and beta-thromboglobulin in antigen-induced asthma before and after indomethacin pretreatment.

E G Shephard, L Malan, C M Macfarlane, W Mouton, J R Joubert
PMCID: PMC1463826  PMID: 2581599

Abstract

The effect of specific antigen challenge on the lung function of eight allergic asthmatic patients after placebo and indomethacin pretreatment has been investigated. Plasma levels of thromboxane B2(TxB2), metabolite of thromboxane A2, 6-keto-PGF1 alpha, metabolite of epoprostenol, (prostacyclin, PGI2) and beta-thromboglobulin (beta TBG) following antigen challenge in these eight patients have also been measured after placebo and indomethacin pretreatment. Each patient underwent two antigen inhalations 1 week apart. One challenge took place after 4 days pretreatment with indomethacin capsules 25 mg four times daily, and the other took place following 4 days placebo pretreatment, one matched capsule four times daily. The order of administration was random but balanced and blind with respect to the patient. Following placebo pretreatment two patients presented with an early antigen response only, four presented with a biphasic antigen response and two presented with a delayed antigen response only. The asthmatic response for each patient was consistent on re-exposure. Indomethacin pretreatment suppressed the delayed antigen induced asthmatic response. This suppression was reproducible. There was a rise in plasma TxB2 levels on antigen challenge following placebo pretreatment but not following indomethacin pretreatment, whereas there was a rise in 6-keto-PGF1 alpha after antigen challenge following indomethacin but not placebo pretreatment. No significant change in plasma beta TBG or platelet counts from control values was observed following antigen challenge with either placebo or indomethacin pretreatment. It is suggested that the production of PGI2 and suppression of TxA2 by indomethacin pretreatment contribute to the suppression of the delayed antigen induced asthmatic response and that platelets play a minimal role in this process.

Full text

PDF
459

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Austen K. F., Orange R. P. Bronchial asthma: the possible role of the chemical mediators of immediate hypersensitivity in the pathogenesis of subacute chronic disease. Am Rev Respir Dis. 1975 Sep;112(3):423–436. doi: 10.1164/arrd.1975.112.3.423. [DOI] [PubMed] [Google Scholar]
  2. Bunn A. E., De Brandt H. M., Vermaak J. C. Analogue device for measurement of area under the maximum expiratory flow-volume curve. Med Biol Eng Comput. 1979 Sep;17(5):695–696. doi: 10.1007/BF02440920. [DOI] [PubMed] [Google Scholar]
  3. Dahlén S. E., Hedqvist P., Hammarström S., Samuelsson B. Leukotrienes are potent constrictors of human bronchi. Nature. 1980 Dec 4;288(5790):484–486. doi: 10.1038/288484a0. [DOI] [PubMed] [Google Scholar]
  4. Fairfax A. J., Hanson J. M., Morley J. The late reaction following bronchial provocation with house dust mite allergen. Dependence on arachidonic acid metabolism. Clin Exp Immunol. 1983 May;52(2):393–398. [PMC free article] [PubMed] [Google Scholar]
  5. Fish J. E., Ankin M. G., Adkinson N. F., Jr, Peterman V. I. Indomethacin modification of immediate-type immunologic airway responses in allergic asthmatic and non-asthmatic subjects: evidence for altered arachidonic acid metabolism in asthma. Am Rev Respir Dis. 1981 Jun;123(6):609–614. doi: 10.1164/arrd.1981.123.6.609. [DOI] [PubMed] [Google Scholar]
  6. FitzGerald G. A., Oates J. A., Hawiger J., Maas R. L., Roberts L. J., 2nd, Lawson J. A., Brash A. R. Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. J Clin Invest. 1983 Mar;71(3):676–688. doi: 10.1172/JCI110814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gardiner P. J., Collier H. O. Specific receptors for prostaglandins in airways. Prostaglandins. 1980 Jun;19(6):819–841. doi: 10.1016/0090-6980(80)90116-1. [DOI] [PubMed] [Google Scholar]
  8. Gresele P., Todisco T., Merante F., Nenci G. G. Platelet activation and allergic asthma. N Engl J Med. 1982 Mar 4;306(9):549–549. [PubMed] [Google Scholar]
  9. Gréen K., Hedqvist P., Svanborg N. Increased plasma levels of 15-keto-13,14-dihydro-prostaglandin F2X after allergen-provoked asthma in man. Lancet. 1974 Dec 14;2(7894):1419–1421. doi: 10.1016/s0140-6736(74)90075-0. [DOI] [PubMed] [Google Scholar]
  10. Hanley S. P., Bevan J., Cockbill S. R., Heptinstall S. A regimen for low-dose aspirin? Br Med J (Clin Res Ed) 1982 Nov 6;285(6351):1299–1302. doi: 10.1136/bmj.285.6351.1299. [DOI] [PubMed] [Google Scholar]
  11. Hanley S. P., Bevan J., Cockbill S. R., Heptinstall S. Differential inhibition by low-dose aspirin of human venous prostacyclin synthesis and platelet thromboxane synthesis. Lancet. 1981 May 2;1(8227):969–971. doi: 10.1016/s0140-6736(81)91733-5. [DOI] [PubMed] [Google Scholar]
  12. Horton E. W. Prostaglandins and smooth muscle. Br Med Bull. 1979 Sep;35(3):295–300. doi: 10.1093/oxfordjournals.bmb.a071591. [DOI] [PubMed] [Google Scholar]
  13. Knauer K. A., Lichtenstein L. M., Adkinson N. F., Jr, Fish J. E. Platelet activation during antigen-induced airway reactions in asthmatic subjects. N Engl J Med. 1981 Jun 4;304(23):1404–1407. doi: 10.1056/NEJM198106043042307. [DOI] [PubMed] [Google Scholar]
  14. Ludlam C. A., Moore S., Bolton A. E., Pepper D. S., Cash J. D. The release of a human platelet specific protein measured by a radioimmunoassay. Thromb Res. 1975 Jun;6(6):543–548. doi: 10.1016/0049-3848(75)90066-3. [DOI] [PubMed] [Google Scholar]
  15. Morris H. G., Sherman N. A., Shepperdson F. T. Variables associated with radioimmunoassay of prostaglandins in plasma. Prostaglandins. 1981 May;21(5):771–788. doi: 10.1016/0090-6980(81)90234-3. [DOI] [PubMed] [Google Scholar]
  16. Needleman P., Moncada S., Bunting S., Vane J. R., Hamberg M., Samuelsson B. Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxides. Nature. 1976 Jun 17;261(5561):558–560. doi: 10.1038/261558a0. [DOI] [PubMed] [Google Scholar]
  17. Omini C., Folco G. C., Viganò T., Rossoni G., Brunelli G., Berti F. Leukotriene-C4 induces generation of PGI2 and TXA2 in guinea-pig in vivo. Pharmacol Res Commun. 1981 Jul;13(7):633–640. doi: 10.1016/s0031-6989(81)80051-3. [DOI] [PubMed] [Google Scholar]
  18. Piper P. J., Samhoun M. N. Stimulation of arachidonic acid metabolism and generation of thromboxane A2 by leukotrienes B4, C4 and D4 in guinea-pig lung in vitro. Br J Pharmacol. 1982 Oct;77(2):267–275. doi: 10.1111/j.1476-5381.1982.tb09295.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Samuelsson B. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science. 1983 May 6;220(4597):568–575. doi: 10.1126/science.6301011. [DOI] [PubMed] [Google Scholar]
  20. Schleimer R. P., Schulman E. S., MacGlashan D. W., Jr, Peters S. P., Hayes E. C., Adams G. K., 3rd, Lichtenstein L. M., Adkinson N. F., Jr Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells. J Clin Invest. 1983 Jun;71(6):1830–1835. doi: 10.1172/JCI110938. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Schulman E. S., Adkinson N. F., Jr, Newball H. H. Cyclooxygenase metabolites in human lung anaphylaxis: airway vs. parenchyma. J Appl Physiol Respir Environ Exerc Physiol. 1982 Sep;53(3):589–595. doi: 10.1152/jappl.1982.53.3.589. [DOI] [PubMed] [Google Scholar]
  22. Shaikh B. S., Bott S. J., Demers L. M. The differential inhibition of prostaglandin synthesis in platelets and vascular tissue in response to aspirin. Prostaglandins Med. 1980 Jun;4(6):439–447. doi: 10.1016/0161-4630(80)90052-x. [DOI] [PubMed] [Google Scholar]
  23. Svenssen J., Strandberg K., Tuvemo T., Hamberg M. Thromboxane A2: effects on airway and vascular smooth muscle. Prostaglandins. 1977 Sep;14(3):425–436. doi: 10.1016/0090-6980(77)90258-1. [DOI] [PubMed] [Google Scholar]
  24. Weissmann G., Smolen J. E., Korchak H. Prostaglandins and inflammation: receptor/cyclase coupling as an explanation of why PGEs and PGI2 inhibit functions of inflammatory cells. Adv Prostaglandin Thromboxane Res. 1980;8:1637–1653. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES